Alzheon Presents Positive Results of ALZ-801 Clinical Studies that Lead to Advancement to Pivotal Phase 3 Study in Alzheimer's Patients with APOE4/4 Homozygous Genotype

Read also

Aligos Therapeutics

Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting

8th AVG and 3rd IMRP 2025 Meeting

Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting

Amgen

Amgen to invest $600m in new US science and innovation hub

Recall Alert

Recall Alert: Popular Supplement for Men Swapped for Erectile Dysfunction Drug